In a major step toward the future of virtual health assessments, NuraLogix has received international certification for the quality and safety of its contactless health monitoring software. The Toronto-based company, known for its Transdermal Optical Imaging (TOI™) technology, announced it has achieved ISO 13485:2016 certification, a globally recognized standard for medical device software development.
This milestone validates the company’s ability to meet the rigorous quality and risk management standards required for Software as a Medical Device (SaMD), enabling broader adoption of its platform in healthcare settings around the world.
NuraLogix Magic Mirror
Contactless Vital Sign Monitoring, Explained
NuraLogix’s core innovation lies in its ability to turn everyday cameras—such as those in smartphones, tablets, or smart mirrors—into powerful health monitoring tools. Using Transdermal Optical Imaging, the company’s software captures and analyzes tiny changes in facial blood flow that aren’t visible to the human eye. These signals are then processed by AI algorithms to estimate vital signs such as:
-
Heart rate
-
Breathing rate
-
Blood pressure
-
Stress levels
Unlike traditional health monitors that require physical contact (think cuffs, wires, or wearables), this system works completely touch-free—a game-changer for telehealth, chronic disease management, and even consumer wellness applications.
The technology is showcased in Anura™, NuraLogix’s proprietary app, which delivers results in under 30 seconds. Users simply look into a camera, and the system handles the rest.
Why Certification Matters in a Virtual-First World
While the idea of checking blood pressure through a smartphone might sound like science fiction, it’s quickly becoming science fact. But with that promise comes risk: health data, especially when used for diagnosis or treatment, must be accurate, reliable, and secure.
That’s where ISO 13485:2016 comes in. This certification confirms that NuraLogix follows strict protocols in its software design, manufacturing processes, risk management, and regulatory compliance. It ensures the technology is fit for clinical use—not just wellness apps.
“This certification marks a significant milestone for NuraLogix and validates the team’s commitment to quality, safety, and regulatory excellence,” said CEO Marzio Pozzuoli. “It reinforces trust in our technology and opens the door to broader adoption across healthcare systems globally.”
The certification also aligns with international medical device standards in Australia, Brazil, Canada, Japan, and the U.S., supporting faster market entry and easier integration with global health systems.
Bridging Consumer Tech and Clinical Care
NuraLogix sits at the intersection of two trends: the rise of telehealth and the consumerization of medical technology. By using devices people already own, the company’s contactless system enables early health screening and ongoing monitoring with minimal friction.
This can help:
-
Clinicians remotely monitor patients with chronic conditions
-
Health systems screen large populations quickly and safely
-
Employers and insurers offer digital wellness programs
-
Individuals track key vitals without purchasing separate devices
But turning smartphones into diagnostic tools also comes with a higher bar for safety and efficacy. Without robust quality systems and independent validation, misreadings or software errors could cause harm. That’s why standards like ISO 13485 are essential—especially for emerging health tech that blends AI, optics, and mobile platforms.
Positioning for Growth in the SaMD Landscape
The Software as a Medical Device market is projected to surpass $86 billion by 2030. With its certification secured and a pipeline of patented technologies, NuraLogix is now better positioned to:
-
Accelerate regulatory approvals
-
Expand B2B partnerships with telehealth platforms, device manufacturers, and digital health firms
-
Compete with other non-contact monitoring solutions entering the market
NuraLogix’s TOI™ technology is protected by multiple patents and offers the ability to detect over 30 health and wellness parameters, many of which are typically only available through in-person assessments or connected devices.
As remote care becomes a permanent fixture of modern healthcare, the ability to deliver clinically trusted measurements from a camera lens may redefine how, where, and when we monitor health.
Learn more about the company and its technology at nuralogix.ai
– This original article was created with AI support.
